Surgical utilization and outcomes for patients with stage IV melanoma in the modern immunotherapy era
Dr. George Molina
The benefit of surgery for patients with stage IV melanoma in the modern era of effective immunotherapy is unclear. Analysis of data in the National Cancer Database (2012-2017; 9800 patients with stage IV, melanoma; 2160 undergoing surgery) found that use of immunotherapy was associated with a lower use of surgery. Patients who received both surgery and immunotherapy had the highest overall survival rates.
